Randomized trial of the effect of drug presentation on asthma outcomes: The American Lung Association Asthma Clinical Research Centers

Journal of Allergy and Clinical Immunology

Volumn 124, Issue 3, 2009, Pages

  Wise, Robert A ^a,b   Bartlett, Susan J ^c   Brown, Ellen D ^b   Castro, Mario ^d   Cohen, Rubin ^e   Holbrook, Janet T ^b   Irvin, Charles G ^f   Rand, Cynthia S ^a   Sockrider, Marianna M ^g   Sugar, Elizabeth A ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Asthma; efficacy; factorial design; montelukast; placebo effect

Indexed keywords

CORTICOSTEROID; MONTELUKAST; PLACEBO;

ADULT; ARTICLE; ASTHMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG ERUPTION; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG INFORMATION; EXPECTATION; FEMALE; FLU LIKE SYNDROME; FOLLOW UP; FORCED EXPIRATORY VOLUME; GASTROINTESTINAL SYMPTOM; HUMAN; KNOWLEDGE; LETHARGY; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPTIMISM; PATIENT ATTITUDE; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHINITIS; SELF CONCEPT; TREATMENT OUTCOME;

EID: 69349103362     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2009.05.041     Document Type: Article

References (38)

1. Price D.D., Finniss D.G., and Benedetti F. A comprehensive review of the placebo effect: recent advances and current thought. Annu Rev Psychol 59 (2008) 565-590
2. De Pascalis V., Chiaradia C., and Carotenuto E. The contribution of suggestibility and expectation to placebo analgesia phenomenon in an experimental setting. Pain 96 (2002) 393-402
3. Bergmann J.F., Chassany O., Gandiol J., Deblois P., Kanis J.A., Segrestaa J.M., et al. A randomised clinical trial of the effect of informed consent on the analgesic activity of placebo and naproxen in cancer pain. Clin Trials Metaanal 29 (1994) 41-47
4. Dahan R., Caulin C., Fiega L., Kanis J.A., Caulin F., and Segrestaa J.M. Does informed consent influence therapeutic outcome? A clinical trial of the hypnotic activity of placebo in patients admitted to hospital. BMJ 293 (1986) 363-364
5. Green M.W., Taylor M.A., Elliman N.A., and Rhodes O. Placebo expectancy effects in the relationship between glucose and cognition. Br J Nutr 86 (2001) 173-179
6. Gryll S.L., and Katahn M. Situational factors contributing to the placebo effect. Psychopharmacology 47 (1978) 253-261
7. Rose D.A., and Kahan T.L. Melatonin and sleep qualities in healthy adults: pharmacological and expectancy effects. J Gen Psychol 128 (2001) 401-421
8. Brody H.B., and Brody D. Placebo and health-II. Three perspectives on the placebo response: expectancy, conditioning, and meaning. Adv Mind Body Med 16 (2000) 216-232
9. Price D.D., Milling L.S., Kirsch I., Duff A., Montgomery G.H., and Nicholls S.S. An analysis of factors that contribute to the magnitude of placebo analgesia in an experimental paradigm. Pain 83 (1999) 147-156
10. Levine J.D., and Gordon N.C. Influence of the method of drug administration on analagesic response. Nature 312 (1984) 755-756
11. Buckalew L.W., and Coffield K.E. An investigation of drug expectancy as a function of capsule color and size and preparation form. J Clin Psychopharmacol 2 (1982) 245-248
12. Buckalew L.W., and Coffield K.E. Drug expectations associated with perceptual characteristics: ethnic factors. Percept Mot Skills 55 (1982) 915-918
13. Branthwaite A., and Cooper P. Analgesic effects of branding in treatment of headaches. BMJ 282 (1981) 1576-1578
14. Joyce D.P., Jackevicius C., Chapman K.R., McIvor R.A., and Kesten S. The placebo effect in asthma drug therapy trials: a meta-analysis. J Asthma 37 (2000) 303-318
15. Spector S., Luparello T.J., Kopetzky M.T., Souhrada J., and Kinsman R.A. Response of asthmatics to methacholine and suggestion. Am Rev Respir Dis 113 (1976) 43-50
16. McFadden E.R., Luparello T., Lyons H.A., and Bleecker E. The mechanism of action of suggestion in the induction of acute asthma attacks. Psychosom Med 31 (1969) 134-143
17. Luparello T., Lyons H.A., Bleecker E.R., and McFadden Jr. E.R. Influences of suggestion on airway reactivity in asthmatic subjects. Psychosom Med 30 (1968) 819-825
18. Kemeny M.E., Rosenwasser L.J., Panettieri R.A., Rose R.M., Berg-Smith S.M., and Kline J.N. Placebo response in asthma: a robust and objective phenomenon. J Allergy Clin Immunol 119 (2007) 1375-1381
19. Kleijnen J., de Craen A.J., van Everdingen J., and Krol L. Placebo effect in double-blind clinical trials: a review of interactions with medications. Lancet 344 (1994) 1347-1349
20. Marlatt G.A., and Rohsenow D.J. Cognitive processes in alcohol use: expectancy and the balanced placebo design. In: Mello N.K. (Ed). Advances in substance abuse: behavioral and biological research. Vol. 1 (1980), JAI Press, Greenwich (Conn) 159-199
21. Mikalsen A., Bertelsen B., and Flaten M.A. Effects of caffeine, caffeine-associated stimuli, and caffeine-related information on physiological and psychological arousal. Psychopharmacology (Berl) 157 (2001) 373-380
22. Hankinson J.L., Odencrantz J.R., and Fedan K.B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159 (1999) 179-187
23. Juniper E.F., O'Byrne P.M., Guyatt G.H., Ferrie P.J., and King D.R. Development and validation of a questionnaire to measure asthma control. Eur Respir J 14 (1999) 902-907
24. National Institutes of Health. 1997. Facts about Controlling your Asthma. National Institutes of Health Publication No. 97-2339.
25. de Craen A.J.M., Roos P.J., de Vries A.L., and Kleijnen J. Effect of colour of drugs: systematic review of perceived effect of drugs and their effectiveness. BMJ 313 (1996) 1624-1626
26. Juniper E.F., Guyatt G.H., Cox F.M., Ferrie P.J., and King D.R. Development and validation of the Mini Asthma Quality of Life Questionnaire. Eur Respir J 14 (1999) 32-38
27. Revicki D.A., Leidy N.K., Brennan-Diemer F., Sorensen S., and Togias A. Integrating patient preferences into health outcomes assessment. Chest 114 (1998) 998-1007
28. Wigal J.K., Stout C., Brandon M., Winder J.A., McConnaughy K., Creer T.L., et al. The Knowledge, Attitude, and Self-efficacy Asthma Questionnaire. Chest 104 (1993) 1144-1148
29. Elashoff J. N Query Advisor User Guide (2000), Statistical Solutions, Cork (Ireland)
30. Malmstrom K., Rodriguez-Gomez G., Guerra J., Villaran C., Piñeiro A., Wei L.X., et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Ann Intern Med 130 (1999) 487-495
31. Diggle P.J., Liang K.Y., and Zeger S.L. Analysis of longitudinal data. Vol. 13 (1994), Clarendon Press, Oxford (England)
32. Hosmer D.W., and Lemeshow S. Applied logistic regression (1998), Wiley and Sons, New York
33. SAS/STAT user's guide, version 8.0 (1999), SAS Institute, Cary (NC)
34. Juniper E.F., Bousquet J., Abetz L., and Bateman E.D. GOAL Committee. Identifying "well-controlled" and "not well-controlled" asthma using the Asthma Control Questionnaire. Respir Med 100 (2006) 616-621
35. Bateman E.D., Boushey H.A., Bousquet J., Busse W.W., Clark T.J., Pauwels R.A., et al. Can guideline-defined asthma control be achieved? The Gaining Optimal Asthma ControL study. Am J Respir Crit Care Med 170 (2004) 836-844
36. Ciccone D.S., Chandler H.K., Pate-Carolan L., Janal M.N., and Lavietes M.H. A test of the symptom amplification hypothesis in patients with asthma. J Nerv Ment Dis 195 (2007) 119-124
37. Goebel M.U., Trebst A.E., Steiner J., Xie Y.F., Exton M.S., Frede S., et al. Behavioral conditioning of immunosuppression is possible in humans. FASEB J 16 (2002) 1869-1873
38. Mahler D.A., Wire P., Horstman D., Chang C.N., Yates J., Fischer T., et al. Effectiveness of fluticasone propionate and salmeterol combination delivered via the Diskus device in the treatment of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 166 (2002) 1084-1091